Correlation Between GlucoTrack and Neuropace

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlucoTrack and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlucoTrack and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlucoTrack and Neuropace, you can compare the effects of market volatilities on GlucoTrack and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlucoTrack with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlucoTrack and Neuropace.

Diversification Opportunities for GlucoTrack and Neuropace

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between GlucoTrack and Neuropace is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding GlucoTrack and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and GlucoTrack is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlucoTrack are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of GlucoTrack i.e., GlucoTrack and Neuropace go up and down completely randomly.

Pair Corralation between GlucoTrack and Neuropace

Given the investment horizon of 90 days GlucoTrack is expected to under-perform the Neuropace. In addition to that, GlucoTrack is 2.24 times more volatile than Neuropace. It trades about -0.2 of its total potential returns per unit of risk. Neuropace is currently generating about 0.13 per unit of volatility. If you would invest  739.00  in Neuropace on September 1, 2024 and sell it today you would earn a total of  321.00  from holding Neuropace or generate 43.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

GlucoTrack  vs.  Neuropace

 Performance 
       Timeline  
GlucoTrack 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlucoTrack has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Neuropace 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

GlucoTrack and Neuropace Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlucoTrack and Neuropace

The main advantage of trading using opposite GlucoTrack and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlucoTrack position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.
The idea behind GlucoTrack and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Transaction History
View history of all your transactions and understand their impact on performance